Key facts
- It has raised $500K; the latest was Early Stage VC in Feb 2026.
- Notable investors include Y Combinator, SBXi.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Baseline AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Baseline AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Baseline AI
Developer of an AI-based documentation software designed for data management of clinical trials. The company automates the protocol for creating case report forms, database models, edit checks, and analysis code, enabling clients from the healthcare and medical industry to quickly review and approve data while minimizing costs.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 2
- Website
- baselinetrials.com/
- Ownership
- Privately Held (backing)
Baseline AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Baseline AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Baseline AI in its N-PORT filings yet. We sweep new filings monthly.